血糖监测设备市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品类型、按应用、最终用户、地区和竞争细分

2022 年，全球血糖监测设备市场估值达到 177.9 亿美元，预计在预测期内将出现显着增长，预计到 2028 年复合年增长率 (CAGR) 为 7.03%。对于糖尿病患者来说至关重要的过程，包括定期检测血糖值。它在将血糖水平维持在目标范围内发挥关键作用，并为有效的糖尿病管理提供了宝贵的见解。这包括监测治疗进展、评估药物对血糖水平的影响以及全面了解病情如何影响血糖水平。

市面上有多种血糖监测设备，俗称血糖仪。这些设备专为满足不同类型的糖尿病而量身定制，包括 1 型、2 型和妊娠糖尿病。血糖监测设备市场的成长可归因于几个关键因素，包括糖尿病盛行率不断上升、监测和诊断工具的技术进步、早期糖尿病检测以及对连续血糖监测设备不断增长的需求。

血糖仪是一种紧凑型电子设备，专门设计用于分析使用刺血针和采血装置透过小刺获得的血液样本。随后，将血液样本放置在一次性测试条上，然后将其插入仪表中。血糖仪透过试纸与血液之间的电化学反应来读取血液中的葡萄糖水平。这些仪表采用电池供电，结构紧凑，可以舒适地握在手掌中。血液样本流经设备内的管道，准确测定葡萄糖浓度，促进高效率且使用者友善的血糖监测。

市场概况
预测期	2024-2028
2022 年市场规模	177.9亿美元
2028 年市场规模	265.2亿美元
2023-2028 年复合年增长率	7.03%
成长最快的细分市场	连续血糖监测
最大的市场	北美洲

主要市场驱动因素

糖尿病盛行率高

糖尿病是一种慢性疾病，当胰臟无法产生足够的胰岛素或无法有效地利用它来调节体内血糖水平时，就会发生糖尿病。如果管理不当，血糖控制失衡可能会导致各种併发症和健康风险。

老年人口增加

预计老年人口的增加将对血糖监测设备的需求产生重大影响。随着全球人口老化，糖尿病（尤其是第 2 型糖尿病）的盛行率正在上升。罹患糖尿病的风险随着年龄的增长而增加。由于胰岛素敏感性降低和缺乏身体活动等因素，老年人更容易患第 2 型糖尿病。因此，越来越多的老年人需要定期监测血糖水平。

医疗保健的进步导致寿命延长，但随着寿命的延长，糖尿病等慢性病的风险也会增加。老年人的寿命越来越长，许多人需要持续的糖尿病管理，需要定期监测血糖。预防保健措施对于控制老年人糖尿病至关重要。定期监测可以及早发现异常的血糖水平，使医疗保健提供者能够及时进行干预，改变生活方式或调整药物。糖尿病是一个全球性的健康问题，影响各个年龄层的人。随着全球糖尿病盛行率持续增长，老年人口仍然是受影响人群的很大一部分，这增加了全球对血糖监测设备的需求。

肥胖率的成长

肥胖症的日益普及预计将对血糖监测设备的需求产生重大影响。肥胖是第 2 型糖尿病发展的一个公认的危险因素，这种疾病的特征是胰岛素功能受损和血糖水平升高。肥胖与第2型糖尿病的发生有密切相关。体内过多的脂肪，特别是腹部周围的脂肪，会导致胰岛素阻抗，即身体细胞对胰岛素无法有效反应。这种胰岛素抗性通常会发展为糖尿病，需要定期监测血糖来控制病情。监测血糖水平对于早期发现具有肥胖相关危险因子的个体的糖尿病至关重要。定期监测使医疗保健提供者能够及时干预生活方式改变或药物治疗，以有效预防或管理糖尿病。

肥胖管理通常涉及生活方式的改变，例如饮食改变和增加体力活动。血糖监测设备为个人提供即时回馈，了解他们的选择如何影响他们的血糖水平，从而激发更健康的行为。血糖监测设备变得更加用户友好和易于使用，使肥胖和糖尿病患者能够积极参与他们的医疗保健。这些设备使患者能够对其日常生活和药物管理做出明智的决定。

技术进步

技术进步有望彻底改变血糖监测领域，从而显着增加对这些设备的需求。这些创新提高了血糖监测仪的准确性、便利性和连接性，使其更加用户友好和有效。 CGM 系统的开发可以即时监测血糖值。这些穿戴式装置提供连续资料，使糖尿病患者和医疗保健提供者能够立即做出治疗决定。由于 CGM 设备能够改善血糖控制并降低低血糖和高血糖风险，因此对 CGM 设备的需求不断增加。

研究人员在开发非侵入式血糖监测技术（例如光学感测器和智慧隐形眼镜）方面取得了重大进展。这些方法消除了指尖采血测试的需要，并提供了更舒适的监测选项，这可以提高患者的依从性和需求。人工智慧和机器学习演算法正在应用于血糖资料分析。这些技术可以预测血糖趋势、检测模式并提供个人化见解，使糖尿病患者能够主动做出有关其健康的决策。

主要市场挑战

监测设备的高成本和复杂性

血糖监测设备虽然可以有效管理糖尿病，但也可能带来一定的挑战。首先，该设备的成本对某些人来说可能是一个障碍，使得最需要它的人无法使用它。此外，监测血糖值的过程可能会很痛苦，给患者带来不适。另一个问题是结果的准确性，因为糖尿病照护设备可能不会总是提供可靠的读数。此外，与糖尿病相关的费用的保险范围通常有限，导致许多医院和医疗中心无法完全支持患者管理病情。缺乏承保或承保资格已成为医疗保健行业日益严重的问题。这些因素共同构成了血糖监测设备市场成长的障碍。

此外，这些设备的使用还存在一些併发症，进一步阻碍了市场的成长。破坏性警报和遗失讯号可能会导致资料缺口，从而难以准确解读血糖读数。此外，有些患者可能会因长时间使用该设备而出现皮肤刺激或沾黏问题。这些复杂情况增加了市场面临的整体障碍。

严格的规范架构

血糖监测 (BGM) 设备市场的成长正受到强大监管框架的挑战。由于美国 FDA 和欧盟欧洲药品管理局 (EMA) 等监管机构对血糖仪等医疗器材实施严格监管，该市场面临重大障碍。这些法规需要进行广泛的临床试验和研究，以确保产品的安全性和有效性，导致耗时且昂贵的过程，可能会延迟新产品的上市。

对于製造商来说，遵守血糖仪准确性和可靠性的严格准则是一项艰鉅且资源密集的任务。此外，监管变化可能会对市场产生不利影响。严格的监管框架给市场带来了重大挑战，影响创新，增加成本，并导致新产品发布延迟，最终阻碍预测期内的市场成长。

主要市场趋势

基于智慧手錶的应用程式

基于智慧手錶的应用是影响血糖监测 (BGM) 设备市场成长的重要趋势。在市场上，越来越倾向于利用基于智慧手錶的应用程式来监测血糖水平。近年来，智慧手錶因其能够追踪心率、睡眠模式、身体活动和其他健康指标等各种活动而受到欢迎。这些应用利用连续血糖监测 (CGM) 感测器来测量用户间质液中的葡萄糖水平。然后收集的资料被传输到智慧手錶，使用户能够查看他们的血糖水平并监控他们随时间的进展。

基于智慧手錶的血糖监测应用程式的显着优势之一是其便利性和谨慎性。使用者可以监测自己的血糖水平，无需携带单独的设备或刺穿手指来获取血液样本。这种便利性使糖尿病患者能够有效地管理自己的病情并实现最佳的血糖控制。因此，使用者可以采取主动措施来调节血糖水平，例如调整饮食或坚持用药。随着穿戴式科技变得更加流行，以及个人在预测期内寻求方便有效的方法来管理自己的健康，基于智慧手錶的血糖监测应用的总体趋势预计将持续下去。

加强策略发展

加强合作等策略发展在推动市场成长方面发挥关键作用。最近的一个例子是罗氏和礼来公司在 2021 年的合作。他们的共同努力重点是加强胰岛素笔治疗的​​管理，这是糖尿病护理的关键方面。此次合作凸显了罗氏致力于创建一个开放的生态系统，将其解决方案、合作伙伴设备和服务整合到糖尿病的整个连续护理过程中。透过利用这种综合方法，罗氏不仅可以满足患者的直接需求，还可以促进医疗保健产业的长期市场成长。

细分市场洞察

产品类型见解

根据产品类型，市场分为两类：自我监测血糖设备和连续血糖监测设备。其中，连续血糖监测设备领域预计在预测期内将呈现最高的年复合成长率（CAGR）。这种显着的增长主要归因于微创手术的日益普及，它为患者提供了更方便、更准确的血糖水平监测方法。随着连续血糖监测设备领域的发展，预计它将在塑造血糖监测技术的未来方面发挥重要作用。

最终使用者见解

根据最终用户细分市场，家庭护理细分市场预计将在预测期内显着增长。推动这一成长的关键因素之一是自我监测血糖的革命性方法，它改变了家庭血糖监测方式。自我监测血糖（SMBG）作为短期血糖监测的首选方法在世界各地被广泛采用。它允许患有或未患有糖尿病的个人在舒适的家中方便地测量血糖水平。这种方法使患者能够密切监测治疗效果，包括饮食、胰岛素、运动和压力管理，从而更好地管理他们的整体健康和福祉。

区域洞察

预计在预测期内，北美将成为全球血糖监测设备市场成长的最大贡献者。 Technavio 的分析师全面解释了这段时期塑造市场的区域趋势和驱动因素。

在糖尿病盛行率不断上升、人们对血糖监测重要性的认识不断提高以及技术进步导致进一步发展等因素的推动下，该地区的市场预计将呈现稳定成长。该市场的主要参与者包括雅培实验室、罗氏诊断、LifeScan、Dexcom 等。美国是北美血糖仪的主要销售市场，其显着成长主要是由于肥胖和糖尿病盛行率的上升。因此，该地区对血糖监测设备和服务的需求大幅增加。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球血糖监测设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（自我监测血糖设备和连续血糖监测设备）
  • 按应用（1 型糖尿病、2 型糖尿病、妊娠期糖尿病）
  • 按最终使用者（家庭护理机构、医院、其他）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美血糖监测设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲血糖监测设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区血糖监测设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲血糖监测设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血糖监测设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非血糖监测设备
  • 沙乌地阿拉伯血糖监测设备
  • 阿联酋血糖监测设备

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球血糖监测设备市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Roche Holding AG
  • Dexcom Inc.
  • Medtronic PLC
  • Arkray Inc.
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon Laboratories Inc.
  • Medisana AG
  • Rossmax International Ltd

第 16 章：策略建议

关于我们及免责声明

In 2022, the Global Blood Glucose Monitoring Devices Market achieved a valuation of USD 17.79 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 7.03% through 2028. Blood glucose monitoring is a vital process for individuals with diabetes, involving the regular testing of blood sugar levels. It plays a pivotal role in maintaining glucose levels within the target range and provides invaluable insights for effective diabetes management. This includes monitoring treatment progress, assessing the impact of medication on blood sugar levels, and gaining a comprehensive understanding of how the condition influences glucose levels.

A variety of blood glucose monitoring devices, commonly known as blood glucose meters, are available in the market. These devices are tailored to cater to different types of diabetes, encompassing Type 1, Type 2, and gestational diabetes. The growth of the Blood Glucose Monitoring Devices Market can be attributed to several key factors, including the escalating prevalence of diabetes, technological advancements in monitoring and diagnostic tools, early diabetes detection, and the growing demand for continuous glucose monitoring devices.

Blood glucose meters are compact electronic devices specially designed for the analysis of blood samples obtained through a small prick using a lancet and lancing device. Subsequently, the blood sample is placed onto a disposable test strip, which is then inserted into the meter. The meter reads the glucose level in the blood through an electrochemical reaction between the test strip and the blood. These meters are battery-powered and compact enough to fit comfortably in the palm of one's hand. The blood sample flows through a tube within the device, and the glucose concentration is accurately determined, facilitating efficient and user-friendly glucose monitoring.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 17.79 Billion
Market Size 2028	USD 26.52 Billion
CAGR 2023-2028	7.03%
Fastest Growing Segment	Continuous Blood Glucose Monitoring
Largest Market	North America

Key Market Drivers

High Prevalence of Diabetes

Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or cannot effectively use it to regulate body sugar levels. This imbalance in blood glucose control can lead to various complications and health risks if not managed properly.

According to the International Diabetes Federation, it is estimated that in 2021, there were approximately 537 million people worldwide living with diabetes. This number is projected to increase to 643 million by 2030 and a staggering 783 million by 2045. The significant growth in the diabetic population is primarily attributed to the rising prevalence of sedentary lifestyles, poor dietary habits, and decreased physical activity. It is worth noting that the impact of diabetes is not evenly distributed across the globe. The prevalence of diabetes has risen more rapidly in low- and middle-income countries compared to high-income countries. This disparity can be attributed to various factors, including limited access to healthcare resources, inadequate education about diabetes management, and socioeconomic challenges.

Given these alarming statistics and trends, the demand for blood glucose monitoring devices is expected to surge in the coming years. These devices play a crucial role in helping individuals with diabetes monitor their blood sugar levels and make informed decisions about their treatment plans. They provide a convenient and efficient way to track glucose levels, thereby empowering individuals to manage their condition effectively and improve their overall quality of life. In conclusion, the increasing prevalence of diabetes, particularly in low- and middle-income countries, underscores the urgent need for effective management strategies and access to proper healthcare resources. The use of blood glucose monitoring devices is one of the key tools in managing diabetes and ensuring better health outcomes for individuals living with this chronic condition.

Increasing Geriatric Population

The increasing geriatric population is expected to have a significant impact on the demand for blood glucose monitoring devices. As the global population ages, the prevalence of diabetes, particularly Type 2 diabetes, is on the rise. The risk of developing diabetes increases with age. Elderly individuals are more prone to Type 2 diabetes due to factors like decreased insulin sensitivity and physical inactivity. As a result, a growing number of seniors require regular monitoring of their blood glucose levels.

Advances in healthcare have led to longer lifespans, but with extended longevity often comes an increased risk of chronic conditions like diabetes. Seniors are living longer, and many require ongoing diabetes management, necessitating regular blood glucose monitoring. Preventive healthcare measures are crucial in managing diabetes among the elderly. Regular monitoring allows for early detection of abnormal blood glucose levels, enabling healthcare providers to intervene promptly with lifestyle modifications or medication adjustments. Diabetes is a global health concern, affecting people of all ages. As the worldwide prevalence of diabetes continues to grow, the elderly population remains a substantial portion of those affected, contributing to the demand for blood glucose monitoring devices on a global scale.

Growth in Obesity Rates

The growing prevalence of obesity is anticipated to have a substantial impact on the demand for blood glucose monitoring devices. Obesity is a well-established risk factor for the development of Type 2 diabetes, a condition characterized by impaired insulin function and elevated blood glucose levels. Obesity is closely linked to the development of Type 2 diabetes. Excess body fat, particularly around the abdomen, can lead to insulin resistance, where the body's cells do not respond effectively to insulin. This insulin resistance often progresses to diabetes, necessitating regular blood glucose monitoring to manage the condition. Monitoring blood glucose levels is crucial for the early detection of diabetes in individuals with obesity-related risk factors. Regular monitoring allows healthcare providers to intervene promptly with lifestyle modifications or medications to prevent or manage diabetes effectively.

Obesity management often involves lifestyle modifications, such as dietary changes and increased physical activity. Blood glucose monitoring devices provide individuals with real-time feedback on how their choices impact their blood glucose levels, motivating healthier behaviors. Blood glucose monitoring devices are becoming more user-friendly and accessible, empowering individuals with obesity and diabetes to actively participate in their healthcare. These devices enable patients to make informed decisions about their daily routines and medication management.

Technological Advancements

Technological advancements are poised to revolutionize the field of blood glucose monitoring, significantly boosting the demand for these devices. These innovations are enhancing the accuracy, convenience, and connectivity of blood glucose monitors, making them more user-friendly and effective. The development of CGM systems allows for real-time monitoring of blood glucose levels. These wearable devices provide continuous data, enabling individuals with diabetes and healthcare providers to make immediate treatment decisions. The demand for CGM devices is on the rise due to their ability to improve glycemic control and reduce the risk of hypoglycemia and hyperglycemia.

Researchers are making significant progress in developing non-invasive glucose monitoring technologies, such as optical sensors and smart contact lenses. These approaches eliminate the need for fingerstick tests and offer more comfortable monitoring options, which can lead to increased patient compliance and demand. AI and machine learning algorithms are being applied to blood glucose data analysis. These technologies can predict blood glucose trends, detect patterns, and provide personalized insights, empowering individuals with diabetes to make proactive decisions about their health.

Key Market Challenges

High-Cost Nature and Complications for Monitoring Devices

The glucose monitoring device, while effective in managing diabetes, can pose certain challenges. Firstly, the cost of the device can be a barrier for some individuals, making it inaccessible to those who need it the most. Additionally, the process of monitoring glucose levels can be painful, causing discomfort for patients. Another concern is the accuracy of the results, as diabetes care devices may not always provide reliable readings. Furthermore, insurance coverage for diabetes-related expenses is often limited, leaving many hospitals and healthcare centers unable to fully support patients in managing their condition. This lack of coverage or qualifications for coverage has become a growing issue in the healthcare industry. These factors, together, act as barriers to the growth of the market for glucose monitoring devices.

Moreover, several complications are associated with the use of these devices, further hindering market growth. Disruptive alerts and lost signals can lead to data gaps, making it challenging to accurately interpret glucose readings. Additionally, some patients may experience skin irritation or adhesive issues due to prolonged use of the devices. These complications add to the overall hindrance faced by the market.

Stringent Regulatory Framework

The Blood Glucose Monitoring (BGM) Devices Market growth is being challenged by a robust regulatory framework. The market faces significant hurdles due to stringent regulations imposed by regulatory bodies such as the US FDA and the European Union's European Medicines Agency (EMA) on medical devices, including blood glucose meters. These regulations necessitate extensive clinical trials and studies to ensure product safety and efficacy, leading to time-consuming and expensive processes that can delay new product launches.

Compliance with strict guidelines for accuracy and reliability of blood glucose meters is a demanding and resource-intensive task for manufacturers. Moreover, regulatory changes can have adverse effects on the market. The stringent regulatory framework poses a significant challenge to the market, impacting innovation, increasing costs, and causing delays in new product launches, ultimately impeding market growth during the forecast period.

Key Market Trends

Smart Watch-Based Apps

Smartwatch-based applications are a significant trend that is influencing the growth of the Blood Glucose Monitoring (BGM) Devices Market. Within the market, there is an increasing inclination towards utilizing smartwatch-based applications for monitoring blood glucose levels. In recent years, smartwatches have gained popularity due to their ability to track various activities such as heart rate, sleep patterns, physical activity, and other health metrics. These applications utilize Continuous Glucose Monitoring (CGM) sensors to measure glucose levels in the user's interstitial fluid. The collected data is then transferred to the smartwatch, enabling users to view their glucose levels and monitor their progress over time.

One of the notable advantages of smartwatch-based blood glucose monitoring applications is their convenience and discretion. Users can monitor their glucose levels without the need for carrying a separate device or performing finger pricks to obtain blood samples. This convenience empowers individuals with diabetes to effectively manage their condition and achieve optimal blood sugar control. Consequently, users can take proactive measures to regulate their glucose levels, such as making dietary adjustments or adhering to medication. The overall trend towards smartwatch-based blood glucose monitoring applications is expected to continue as wearable technology becomes more prevalent and individuals seek convenient and effective methods to manage their health during the forecast period.

Increasing Strategic Developments

Increasing strategic developments, such as collaborations, play a pivotal role in driving market growth. A recent example of this is the collaboration between Roche and Eli Lilly and Company in 2021. Their joint efforts are focused on enhancing the management of insulin pen therapy, a critical aspect of diabetes care. This collaboration underscores Roche's commitment to creating an open ecosystem that integrates its solutions, partner devices, and services across the entire continuum of care in diabetes. By leveraging this comprehensive approach, Roche is not only addressing the immediate needs of patients but also facilitating long-term market growth in the healthcare industry.

Segmental Insights

Product Type Insights

Based on the product type, the market is divided into two categories: self-monitoring glucose devices and continuous glucose monitoring devices. Among these, the continuous glucose monitoring devices segment is projected to exhibit the highest compound annual growth rate (CAGR) during the forecast period. This remarkable growth can be primarily attributed to the increasing adoption of minimally invasive procedures, which offer patients a more convenient and accurate way of monitoring their glucose levels. With the continuous glucose monitoring devices segment gaining traction, it is expected to play a significant role in shaping the future of glucose monitoring technology.

End User Insights

Based on the end user segment, the home care segment is projected to experience significant growth during the forecast period. One of the key factors driving this growth is the revolutionary approach of self-monitoring of blood glucose, which has transformed home-based glucose monitoring. Self-monitoring blood glucose (SMBG) is widely adopted worldwide as the preferred method for short-term glucose monitoring. It allows individuals, with or without diabetes, to conveniently measure their blood sugar levels in the comfort of their own homes. This approach empowers patients to closely monitor the effects of their treatment, including diet, insulin, exercise, and stress management, leading to better management of their overall health and well-being.

Regional Insights

North America is projected to be the largest contributor to the growth of the global blood glucose monitoring devices market during the forecast period. Technavio's analysts have comprehensively explained the regional trends and drivers shaping the market in this period.

The market in this region is expected to exhibit steady growth, driven by factors such as the increasing prevalence of diabetes, growing awareness of the significance of blood glucose monitoring, and technological advancements leading to further developments. Key players in this market include Abbott Laboratories, Roche Diagnostics, LifeScan, Dexcom, and others. The United States stands as the leading sales market for blood glucose meters in North America, experiencing significant growth primarily due to the rising prevalence of obesity and diabetes. Consequently, the demand for blood glucose monitoring devices and services in the region has witnessed a substantial increase.

Key Market Players

• Roche Holding AG

• Dexcom Inc.

• Medtronic PLC

• Arkray Inc.

• Ascensia Diabetes Care

• Agamatrix Inc.

• Bionime Corporation

• Acon Laboratories Inc.

• Medisana AG

• Rossmax International Ltd.

Report Scope:

In this report, the Global Blood Glucose Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Glucose Monitoring Devices Market, By Product Type:

• Self-Monitoring Glucose Devices
• Continuous Glucose Monitoring Devices

Blood Glucose Monitoring Devices Market, By Application:

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Blood Glucose Monitoring Devices Market, By End User:

• Home Care Settings
• Hospital
• Others

Blood Glucose Monitoring Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Monitoring Devices Market.

Available Customizations:

• Global Blood Glucose Monitoring Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Glucose Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
    • 5.2.1.1. Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets)
    • 5.2.1.2. Continuous Glucose Monitoring Devices (Sensors, Transmitters & receivers, Integrated Insulin Pumps)
  • 5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
  • 5.2.3. By End User (Home Care Settings, Hospital, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Blood Glucose Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Glucose Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Glucose Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Glucose Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Blood Glucose Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Glucose Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Blood Glucose Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Blood Glucose Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Blood Glucose Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Glucose Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Blood Glucose Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blood Glucose Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Glucose Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Glucose Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Glucose Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Glucose Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Blood Glucose Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Glucose Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Blood Glucose Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Blood Glucose Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Blood Glucose Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Glucose Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Blood Glucose Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Blood Glucose Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Blood Glucose Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Roche Holding AG
  • 15.5.2. Dexcom Inc.
  • 15.5.3. Medtronic PLC
  • 15.5.4. Arkray Inc.
  • 15.5.5. Ascensia Diabetes Care
  • 15.5.6. Agamatrix Inc.
  • 15.5.7. Bionime Corporation
  • 15.5.8. Acon Laboratories Inc.
  • 15.5.9. Medisana AG
  • 15.5.10. Rossmax International Ltd

16. Strategic Recommendations

About Us & Disclaimer